CAS: 2756-87-8; (E)-4-Methoxy-4-Oxobut-2-Enoic Acid

该化合物其结构特征为熏蒸酸的甲基酯;一种无色的黄色液,其气味略微甜,可溶于水和酒精等极溶剂;MMF因其在治疗多发性硬化症方面的作用而闻名于世,它作为免疫性分子剂;该化合物的结构具有双重联系,有助于其反应性和进行各种化学转化的潜力;其分子重量相对较低,被归类为二色体酸衍生物;在安全方面,MMF应谨慎处理,因为它在接触时可能造成皮肤和眼部刺激;其稳定性受环境因素的影响,并且通常储存在冷干的地方以保持其完整性;

结构式图片

相似化合物

141-05-9 623-91-6 624-48-6

欧盟法规

REACH注册C&L通报REACH预注册

上下游产品

CAS号3052-50-4 马来酸单甲酯 | CAS号624-49-7 富马酸二甲酯 | CAS号108-31-6 顺酐 | CAS号623-43-8 巴豆酸甲酯 | CAS号67-56-1 甲醇 | CAS号110-17-8 富马酸,反丁烯二酸 | CAS号17081-97-9 methyl 4-chloro... | CAS号5837-72-9 富马醛酸甲酯 | CAS号57314-32-6 Maleinaldehydsa... | CAS号2459-05-4 富马酸单乙酯 | CAS号2987-87-3 2-Butenoic acid... | CAS号6270-74-2 3-氧代-3,4-二氢-2H-... | CAS号7556-63-0 甲基[2H-1,4-苯并噻嗪-... | CAS号33176-41-9 2-(2-氨基-4-氧代-1,... | CAS号17081-97-9 methyl 4-chloro...

合成工艺路线路线简述

    巴豆酸甲酯置于叔丁基过氧化氢,[rh2(Cap)4*2Ch3Cn]体系中,用 水,1,2-二氯乙烷 用作溶剂,化学反应 40.0H,以32%的收率获得富马酸单甲酯
    参考文献:己内酰胺二铑通过水性叔丁基过氧化氢催化烯丙基氧化:叔丁基过氧自由基的作用
    标题:己内酰胺二铑通过水性叔丁基过氧化氢催化烯丙基氧化:叔丁基过氧自由基的作用
    摘要:Dirhodium (II) 己内酰胺在生成叔丁基过氧自由基方面表现出最佳效率,叔丁基过氧自由基是氢原子提取的选择性试剂.这些氧化反应发生在叔水溶液中-丁基氢过氧化物 (Tbhp) 没有快速水解二铑上的己内酰胺配体.烯酮的烯丙基氧化以中等至高产率产生相应的烯二酮,其应用包括甾体烯酮的烯丙基氧化.虽然亚甲基氧化成酮更有效,但也可以实现甲基氧化成羧酸.在与其他金属催化剂的比较研究中描述了己内酰胺二铑 (II) 作为 Tbhp 烯丙基氧化的催化剂的优越效率(催化剂的摩尔%,转化率).不同的催化剂以相同的相对产率产生基本上相同的产物混合物表明催化剂不参与产物形成步骤.烯酮烯丙基氧化研究产生的机理影响为控制产物形成的因素提供了新的见解.以前未公开的歧化途径,由已发现混合过氧化物的叔丁氧基自由基,用于通过烯丙基氧化形成酮产物.
    Doi:10.1021/jo8021132

    海关参考信息

    专利信息


    专利号:WO-2017046598-A1
    优先权日:2015-09-16
    标题:Treatment of acute inflammatory disorders
    发明人:CRISANTI ANDREA; CANAVESE MIRIAM
    权利人:CRISANTI ANDREA; IMP INNOVATIONS LTD
    摘要:The present invention relates to a VEGF receptor agonist for use in the treatment of an acute inflammatory disorder associated with the overproduction of pro-inflammatory cytokine, administered with an agent that induces the synthesis of Nrf2. The invention also relates to pharmaceutical combinations comprising a VEGF receptor agonist and an agent that induces the synthesis of Nrf2, and kits comprising these agents. The described uses, combinations and methods may prevent or reduce the dis-regulated activation of an inflammatory response and reduce endothelial damage.

    专利号:US-10336912-B2
    优先权日:2014-08-01
    标 题 :Methods for producing and using aqueous polyurethane/polyacrylate hybrid dispersions and use of said aqueous polyurethane/polyacrylate hybrid dispersions in coating agents
    发明人:JAHNS EKKEHARD; MANGEL TIMO; ROESCH CHRISTINE; ROMANATO PAOLA; BURK YENI; PAKUSCH JOACHIM
    权利人:BASF SE
    摘要:The present invention provides an aqueous polyurethane (PU)-polyacrylate hybrid dispersion obtainable by free radical polymerization of at least one acrylate polymer (A1) in the presence of at least one polyurethane (P1), a process for preparing these aqueous polyurethane-polyacrylate hybrid dispersions, wherein said process comprises a) preparing an aqueous polyurethane dispersion and b) using the polyurethane dispersion thus prepared as raw material for the further synthesis of a polyacrylate dispersion, and the use of the hybrid dispersion thus obtained as binder in filled coating materials, particularly as a binder for flexible roof coatings.

    专利号:WO-2023213264-A1
    优先权日:2022-05-05
    标 题 :Synthesis of amide compound and use thereof
    发明人:WANG ZHAOYIN; ZHANG JIAN; CAO JINRUI
    权利人:SHANGHAI INST ORGANIC CHEMISTRY CAS
    摘要:The present invention relates to a novel oleanamide derivative for activating a KEAP/NRF2/ARE signaling pathway. The compound of the present invention is represented by general formula (I), wherein L, R 3 , R 4 , Z, and n are set forth in the description specification and the claims. Also disclosed are a method for preparing the compound represented by general formula I and an activity test result thereof for activating the KEAP/NRF2/ARE signaling pathway. The compound represented by general formula (I) of the present invention can be used for treating and preventing multiple sclerosis (MS), Alzheimer's disease (AD), Parkinson's disease (PD), Huntington's disease (HD), amyotrophic lateral sclerosis (ALS), Friedreich's ataxia (FRDA), spinal muscular atrophy (SMA), neuromyelitis optica (NMO), spinocerebellar ataxia (SCA), and other neurodegenerative diseases, and can also be used for treating cerebral apoplexy, autoimmune diseases, diabetes, kidney diseases, and other chronic diseases.

    专利号:US-10626076-B2
    优先权日:2014-03-17
    标题:Process for the synthesis of dimethyl fumarate
    发明人:PULLAGURLA MANIK REDDY; RANGISETTY JAGADEESH BABU; NANDAKUMAR MECHERIL VALSAN; RADHA NAGARAPU
    权利人:BIOPHORE INDIA PHARMACEUTICALS PVT LTD; BIOPHORE INDIA PHARMAEUTICALS PVT LTD
    摘要:The present invention describes an improved process for the industrial scale production of dimethyl fumarate. The process involves a one-pot ring opening reaction of maleic anhydride to monomethyl maleate and isomerization into the corresponding monomethyl fumarate in presence of a Lewis acid. Finally the mono methyl fumarate was converted into the dimethyl fumarate by an acid catalyzed esterification reaction.

    专利号:US-6599972-B2
    优先权日:1996-12-24
    标 题 :Latex compositions containing ethylenically unsaturated esters of fatty compounds and applications thereof
    发明人:THAMES SHELBY FRELAND; PANJNANI KAMLESH GOPICHAND; FRUCHEY OLAN STANLEY
    权利人:UNIV SOUTHERN MISSISSIPPI
    摘要:Novel latex or emulsion compositions containing internally plasticizing and crosslinkable monomers derived from traditional semi-drying or non-drying oils are disclosed and claimed. The monomers are ethylenically unsaturated derivatives of long-chain olefinic compounds. Preferred embodiments include latex formed from acrylate or methacrylate esters of fatty alcohols. A process for the synthesis of the latex composition is also disclosed, which involves (a) polymerization of the ethylenically unsaturated derivatives of a long-chain olefinic compound in an aqueous phase with at least one other copolymerizable monomer; and (b) blending of so formed polymer with at least one drier and a surfactant to form the novel latex or emulsion compositions. These compositions form films at low minimum film forming temperatures (MFT) ranging from -5 to 10° C. and cure to above ambient glass transition (Tg) polymers without the use of traditional organic cosolvents which contribute to environmental pollution via volatile organic compounds (VOCs) emissions. These compositions are therefore useful in waterborne coatings, contact and pressure sensitive adhesives, and inks.

    专利号:US-5527613-A
    优先权日:1992-04-10
    标 题:Synthesis of latex capsules
    发明人:BLANKENSHIP ROBERT M; NOVAK RONALD W; NEYHART CLARENCE J; VOGEL MARTIN
    权利人:ROHM & HAAS
    摘要:The present invention is concerned with core and shell polymeric particles having microvoids in the core and one or more channels connecting the microvoids to the exterior of the particle. These particles, or LCAPs are produced by forming a core of polymeric acid, encasing the core in a shell polymer permeable to base, and then neutralizing the core such that the core swells, causing the shell to 'explode' in a controlled fashion. This controlled explosion causes channels to form in the shell. n These particles can be used as control release devices for target compounds, to impart reinforcing properties to acrylic films, as an opacifying agent in coating compositions, and as a supplement or replacement of part or all of the pigmentary material or extenders that would otherwise be used in such coating compositions.
    渭南金地圣科技有限责任公司
    ⚠️ 未注册 · 未认证企业
    ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
    数据来源于公开网络搜索,平台未作核实,请自行辨别。
    🏢敬请 企业认领
    🏬开设公司展台
    📢获取免费会员权益
    🎖️点亮专属注册企业标签
    📇展现公司完整信息 样本查看立即注册认领 →
    网址: http://www.fumaric-acid.com
    企业联系电话:0913-2195485 13992360862👤
    📞渭南金地圣科技有限责任公司 ⚠️参考联系方式
    联系人:车万忠
    电话:0913-2195485 13992360862
    手机:13992360862
    传真:0913-2196628
    邮箱:expo@fumaric-acid.com
    通信地址: 陕西省渭南市经开区锦华大街中段
    邮编: 714000
    🆔 联系时候可告知是从"百琢研"平台获取的信息.
    ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

    地址:陕西省渭南市经开区锦华大街中段
    ⚠️ 未注册 · 未认证企业
    注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别
    ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
    渭南高新区惠丰新材料科技有限公司
    ⚠️ 未注册 · 未认证企业
    ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
    数据来源于公开网络搜索,平台未作核实,请自行辨别。
    🏢敬请 企业认领
    🏬开设公司展台
    📢获取免费会员权益
    🎖️点亮专属注册企业标签
    📇展现公司完整信息 样本查看立即注册认领 →
    网址: http://www.sxhfhg.com
    企业联系电话:0913-2195382 -13309133270👤
    📞渭南高新区惠丰新材料科技有限公司 ⚠️参考联系方式
    联系人:刘新纪
    电话:0913-2195382 -13309133270
    手机:13309133270
    传真:0913-2197705
    邮箱:sales@sxhfhg.com
    通信地址: 陕西省渭南市高新技术产业开发区华山大街北侧
    邮编: 714000
    🆔 联系时候可告知是从"百琢研"平台获取的信息.
    ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

    地址:陕西省渭南市高新技术产业开发区华山大街北侧
    ⚠️ 未注册 · 未认证企业
    注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别
    ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
    交大瑞森渭南化学工业有限责任公司
    ⚠️ 未注册 · 未认证企业
    ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
    数据来源于公开网络搜索,平台未作核实,请自行辨别。
    🏢敬请 企业认领
    🏬开设公司展台
    📢获取免费会员权益
    🎖️点亮专属注册企业标签
    📇展现公司完整信息 样本查看立即注册认领 →
    网址: http://www.fumaric-acid.com
    电话: 86-0913-2195485 2096159👤
    📞交大瑞森渭南化学工业有限责任公司 ⚠️参考联系方式

    销售电话:86-0913-2195485 2096159
    邮箱:sales@fumaric-acid.com
    🆔 联系时候可告知是从"百琢研"平台获取的信息.
    ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

    ⚠️ 未注册 · 未认证企业
    注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别 ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
    陕西省渭南市惠丰化学工业有限责任公司
    ⚠️ 未注册 · 未认证企业
    ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
    数据来源于公开网络搜索,平台未作核实,请自行辨别。
    🏢敬请 企业认领
    🏬开设公司展台
    📢获取免费会员权益
    🎖️点亮专属注册企业标签
    📇展现公司完整信息 样本查看立即注册认领 →
    网址: http://www.sxhfhg.com
    电话: 0913-8167678 2195382👤
    📞陕西省渭南市惠丰化学工业有限责任公司 ⚠️参考联系方式

    销售电话:0913-8167678 2195382
    邮箱:sales@sxhfhg.com
    🆔 联系时候可告知是从"百琢研"平台获取的信息.
    ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

    ⚠️ 未注册 · 未认证企业
    注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别 ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
    武汉裕清嘉衡药业有限公司
    ⚠️ 未注册 · 未认证企业
    ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
    数据来源于公开网络搜索,平台未作核实,请自行辨别。
    🏢敬请 企业认领
    🏬开设公司展台
    📢获取免费会员权益
    🎖️点亮专属注册企业标签
    📇展现公司完整信息 样本查看立即注册认领 →
    网址: http://www.jiahengpharma.com
    企业联系电话:15926260338👤
    📞武汉裕清嘉衡药业有限公司 ⚠️参考联系方式
    联系人:刘经理
    电话:15926260338
    手机:15926260338
    传真:027-83855312
    邮箱:2668571332@qq.com
    通信地址: 武汉市东西湖区金银湖街环湖中路A-2栋
    邮编: 430010
    🆔 联系时候可告知是从"百琢研"平台获取的信息.
    ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

    地址:武汉市东西湖区金银湖街环湖中路A-2栋
    ⚠️ 未注册 · 未认证企业
    注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别
    ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
    第 1 / 1 页
    现货

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式

    主要参考文献

    参考标题:A Novel And Efficient Stereo-Controlled Synthesis Of Hexahydroquinolinones Via The Diene-Transmissive Hetero-Diels-Alder Reaction Of Cross-Conjugated Azatrienes With Ketenes And Electrophilic Dienophiles
    作者:Satoru Kobayashi,Tomomi Semba,Taku Takahashi,Satoko Yoshida,Kotaro Dai,Takashi Otani,Takao Saito |发布日期:2009.1
    摘要:Factors And The Electronic Demand Of The Substituents. The Second Diels-Alder Reaction Of The Initial [4+2] Cycloadducts With Electron-Deficient Dienophiles (Tcne, N-Phenylmaleimide) Stereoselectively Yielded Hexahydroquinolinone Derivatives. Similarly, A Tandem Intermolecular-Intramolecular Mode Of The Aza-Dthda Reactions Produced Tetracyclic Nitrogen-Containing Heterocycles In A Regio- And Stereoselective

    合成参考文献


    摘要:S120 | DUSTCT2024 | Substances from Second NORMAN Collaborative Dust Trial | DOI:10.5281/zenodo.13835254
    摘要:Kleemann, A.; Engel, J.; Kutscher, B.; Reichert, D., Pharmaceutical Substances[Online], Thieme: Stuttgart, (2021)
    摘要:Sartori, G.; Maggi, R., Science of Synthesis, (2005) 18, 675.
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知